Search Results for "Hydrocodone Bitartrate 7 5 Mg"

12:57 EDT 29th August 2015 | BioPortfolio

Matching Channels

None

Matching News

Acura to develop hydrocodone/APAP tablets using Limitx technology

US-based Acura Pharmaceuticals has started developing an immediate-release hydrocodone bitartrate with acetaminophen tablet (hydrocodone/APAP) incorporating its new LIMITX abuse deterrent technology.

Acura Pharmaceuticals to Develop Abuse Deterrent Hydrocodone With Acetaminophen

Acura Pharmaceuticals Inc., announced today that it is initiating development of an immediate-release hydrocodone bitartrate with acetaminophen tablet ("hydrocodone/APAP") incorporating Acura's novel ...

Zogenix Closes Sale Of Zohydro ER Business To Pernix

SAN DIEGO, April 24, 2015 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of central nervous system (CNS) disorders,...

Survey of hydrocodone patients shows schedule changes negatively impact treatment

A survey of pain patients to assess the effects of rescheduling hydrocodone has shown that it negatively…

Developing a Genetically Engineered Yeast for Faster Opioid Production

A study conducted by Stanford researchers led by Christina Smolke developed a technique that can hasten the production of hydrocodone. Hydrocodone and its chemical relatives, such as morphine and oxyc...

Procysbi cysteamine bitartrate delayed-release capsules regulatory update

FDA expands approval of Raptor's cystinosis drug

Raptor Pharmaceutical has won FDA approval for the expanded use of delayed-release Procysbi, or cysteamine bitartrate, in ped -More- 

FDA OKs Expanded Use of Procysbi for Children as Young as 2

Cysteamine bitartrate delayed-release capsules were first approved in 2013 for those aged 6 years and older with the rare life-threatening metabolic lysosomal storage disorder nephropathic cystinosis....

Matching PubMed Articles

Clinical efficacy of hydrocodone-acetaminophen and tramadol for control of postoperative pain in dogs following tibial plateau leveling osteotomy.

OBJECTIVE To evaluate clinical efficacy of hydrocodone-acetaminophen and tramadol for treatment of postoperative pain in dogs undergoing tibial plateau leveling osteotomy (TPLO). ANIMALS 50 client-own...

Pharmacokinetics of hydrocodone and tramadol administered for control of postoperative pain in dogs following tibial plateau leveling osteotomy.

OBJECTIVE To evaluate the pharmacokinetics of hydrocodone (delivered in combination with acetaminophen) and tramadol in dogs undergoing tibial plateau leveling osteotomy (TPLO). ANIMALS 50 client-owne...

Individualized Hydrocodone Therapy Based on Phenotype, Pharmacogenetics, and Pharmacokinetic Dosing.

(1) To quantify hydrocodone (HC) and hydromorphone (HM) metabolite pharmacokinetics with pharmacogenetics in CYP2D6 ultra-rapid (UM), extensive (EM) and poor (PM) metabolizer phenotypes. (2) To develo...

An Analysis of Rescue Medication Utilization from a 3-Month, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Low Back Pain Treated with Single-Entity, Twice-Daily, Extended-Release Hydrocodone.

To evaluate the durability of pain relief provided by a new formulation of single-entity, hydrocodone extended-release (ER) (Zohydro(®) ER) throughout the 12-hour dosing interval by examining pattern...

Chemisorptive enantioselectivity of chiral epoxides on tartaric-acid modified Pd(111): three-point bonding.

The chemisorption of two chiral molecules, propylene oxide and glycidol, is studied on tartaric-acid modified Pd(111) surfaces by using temperature-programmed desorption to measure adsorbate coverage....

Search Whole site using Google

Loading

Advertisement
 
Advertisement
 
Advertisement Advertisement